Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Strategy on the Increment of H. Pylori Eradication Rate and Investigating the Gastric Pathology and Antimicrobial Resistance in Diabetic Patients

NCT02466919 is registered in ClinicalTrials.gov with Chung-Tai Wu as lead sponsor.

NCT NCT02466919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02466919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Strategy on the Increment of H. Pylori Eradication Rate and Investigating the Gastric Pathology and Antimicrobial Resistance in Diabetic Patients
Lead sponsor
Chung-Tai Wu
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2014
Completion date
September 30, 2016
Enrollment
114 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection